Drug developers need to integrate better, more predictive in vitro models into their pre-clinical activities. A greater understanding of human-based biology well in advance of the clinic will enable improved early stage drug discovery and development decision making. Sponsoring or exhibiting at the 3rd Annual Developing More Predictive In Vitro Models Summit represents an industry-leading opportunity to access key decision makers within the world’s foremost pharmaceutical and biotech companies. This meeting is specifically designed to discover new opportunities and discuss solutions to some of the biggest challenges currently being faced during pre-clinical drug development.
When you work with Hanson Wade you work with a partner focused on your success. Your investment in both time & money needs to generate a return.
Our clients want that too and that’s why they work with us. They want to reach a targeted audience and eliminate wastage from their marketing activities. They work with us because we deliver results. We’re proud of this fact.
Our research identifies ground breaking issues and allows you to influence industry thinking at an early stage. Our expertise is recognized and respected by the industry. And our events are focused, leading edge and attended by people looking for knowledge before making decisions.
Contact us now to understand more about sponsorship packages & pricing.
Contact Miles Harley on +44 (0) 20 3141 8797 or email mharley@hansonwade.com
Feedback from past sponsors:
"These are relevant, well-organized events with a comprehensive speaker panel featuring the key thought leaders in the industry and are intelligent, forward thinking and discussion-provoking" Qiagen
"First class meeting - incredible opportunity to meet directly with a broad range of decison makers in a growing field" Quanta Biodesign